XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Equity - Stock Option Activity (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
 6 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Number of Shares (in thousands)    
Beginning balance (in shares) | shares 22,407  
Options exercised (in shares) | shares (2,380)  
Options forfeited or expired (in shares) | shares (708)  
Ending balance (in shares) | shares 19,319 22,407
Vested and exercisable, at end of period (in shares) | shares 11,804  
Vested and expected to vest, at end of period (in shares) | shares 18,740  
Weighted-Average Exercise Price    
Beginning balance (in dollars per share) | $ / shares $ 4.39  
Exercised (in dollars per share) | $ / shares 3.05  
Forfeited or expired (in dollars per share) | $ / shares 5.47  
Ending balance (in dollars per share) | $ / shares 4.51 $ 4.39
Weighted average exercise price, vested and exercisable at period end (in dollars per share) | $ / shares 2.93  
Weighted average exercise price, vested and expected to vest at period end (in dollars per share) | $ / shares $ 4.44  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Average remaining contractual term, outstanding 6 years 1 month 13 days 6 years 6 months 21 days
Average remaining contractual term, vested and exercisable at period end 5 years 4 months 24 days  
Average remaining contractual term, vested and expected to vest at period end 6 years 1 month 2 days  
Aggregate intrinsic value, outstanding | $ $ 322,735 $ 627,187
Aggregate intrinsic value, vested and exercisable at period end | $ 215,941  
Aggregate intrinsic value, vested and expected to vest at period end | $ $ 314,519